“Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s598. doi:10.25251/2a8shm52.